OR WAIT 15 SECS
The company will showcase its line of connected devices at and its new PureHale portable drug delivery device designed for upper respiratory care.
On Sept. 12, 2018, Aptar Pharma, a drug delivery systems provider, announced it will be presenting its new PureHale portable drug delivery device, at CPhI Worldwide, which will be held Oct. 9–11, 2018 in Madrid. PureHale is is designed for upper respiratory care.
The company also will be showcasing its new connected drug delivery devices designed to help increase dose adherence and improve patient health outcomes; gamma-sterilized drug delivery components to reduce bioburden; and the company’s Support Services initiative, a portfolio of stage-specific development packages.
In addition to showcasing its product and services, Aptar Pharma executives will be delivering three Pharma Insight Briefings:
“Through a wide range of consulting and services, Aptar Pharma innovates around delivery routes, effective drug delivery, testing and regulatory requirements with partners ranging from small-scale R&D firms to the largest international pharmaceutical companies. We look forward to launching our Support Services initiative at CPhI and working with our customers to meet their development needs,” said Guillaume Brouet, vice president Analytical, Regulatory and Scientific Affairs at Aptar Pharma, in a press release.
Visit Aptar Pharma at stand 4D10.
Source: Aptar Pharma